menu
    • menu

    Company profile for Trigone Pharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Trigone Pharma's product is designed to provide longer exposure of the urinary tract tissue to medications. It enables localized therapy to be a highly effective treatment option by increasing the sustained release of drugs and dwell time in the bladder for safe therapeutic effect and improved patient compliance. Our product integrates well-established regulatory compliant components that present effective, safe, easy-to-handl...
    Trigone Pharma's product is designed to provide longer exposure of the urinary tract tissue to medications. It enables localized therapy to be a highly effective treatment option by increasing the sustained release of drugs and dwell time in the bladder for safe therapeutic effect and improved patient compliance. Our product integrates well-established regulatory compliant components that present effective, safe, easy-to-handle, and user-friendly treatment administration at 1-4 weeks intervals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Trigone PharmaIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    15 HaTidhar Street, Raanana
    Telephone
    Telephone
    +972-9-7403336
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.trigonepharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Relmada Therapeutics Licenses Bladder Cancer Candidate NDV-01
    Relmada Therapeutics Licenses Bladder Cancer Candidate NDV-01

    25 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/25/3048612/0/en/Relmada-Therapeutics-Licenses-Phase-2-Bladder-Cancer-Candidate-NDV-01-from-Trigone-Pharma-Ltd.html

    GLOBENEWSWIRE
    25 Mar 2025
    Share Share
    Trigone Pharma Announces a Strategic Collaboration with 4C Biomed
    Trigone Pharma Announces a Strategic Collaboration with 4C Biomed

    20 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/20/2299879/0/en/Trigone-Pharma-Announces-a-Strategic-Collaboration-with-4C-Biomed-to-Develop-a-Novel-Treatment-for-High-Grade-Bladder-Cancer.html

    GLOBENEWSWIRE
    20 Sep 2021
    Share Share
    Trigone Pharma Announces the Initiation of a Phase 2 Clinical Trial of TRG-100
    Trigone Pharma Announces the Initiation of a Phase 2 Clinical Trial of TRG-100

    13 Aug 2021

    // GLOBENEWS WIRE

    https://www.globenewswire.com/news-release/2021/08/13/2280468/0/en/Trigone-Pharma-Announces-the-Initiation-of-a-Phase-2-Clinical-Trial-of-TRG-100-in-Patients-with-Interstitial-Cystitis-Bladder-Pain-Syndrome.html

    GLOBENEWS WIRE
    13 Aug 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search